Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

A woman who died in a vape fire in her cell may have been saved if the prison was fitted with automatic alarms, an inquest ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

NIK is the central regulator of the non-canonical NF-κB pathway, which is triggered by signaling from a subset of TNFR members. Upon receptor crosslinking by corresponding ligands, TRAFs and cIAP1/2 ...

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

Researchers engineered immune cells that protect insulin-producing cell transplants, bringing scientists closer to a cure for type 1 diabetes.

Green tea contains beneficial compounds that may support immune health by reducing inflammation, fighting oxidative stress, ...

Could bacteria replace your eye drops? Mice study says maybe In A Nutshell Researchers engineered a naturally occurring eye bacterium to secrete an anti-inflammatory healing protein directly on the ...

Discovered in 1964 by Anthony Epstein, Yvonne Barr, and Bert Achong, the Epstein-Barr virus (EBV) has intrigued tumor virologists due to its unique behavior. Typically, EBV establishes a lifelong, ...

Our immune system relies on T cells to fight infections. But T cells don't just show up and react—first, they train, get a game plan, and coordinate their defenses in lymphoid organs. Researchers have ...

High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...